ESCMID Online Lecture Library. by author
|
|
- Brook Palmer
- 6 years ago
- Views:
Transcription
1 . Diagnostic molecular microbiology: first and next 25 years Mario Poljak Institute of Microbiology and Immunology Faculty of Medicine, University of Ljubljana, Slovenia
2
3 Molecular methods methods based on the detection and partial or complete characterisation of microbial DNA or RNA in the clinical sample - diagnostic tests - epidemiological tools - research tools
4 Molecular methods dramatically changed clinical microbiology allowed discovery of several clinically important and previously unrecognized or uncultivable pathogens reduced the dependency of laboratory on culture-based methods became gold diagnostic standards for several microorganisms (C. trachomatis, HSV encephalitis, enteroviral meningitis, CMV reactivation, hepatitis C, )
5 . Diagnostic molecular microbiology: first and next 25 years Mario Poljak Institute of Microbiology and Immunology Faculty of Medicine, University of Ljubljana, Slovenia
6 David H. Persing American Society for Microbiology, Jan 1993
7
8 standardisation automation miniaturisation
9 standardisation automation miniaturisation
10 - Sensitive and specific detection of PCR products - Control of PCR-amplicon carryover contamination
11 standardisation automation miniaturisation
12
13 Molecular methods Commercially interesting microorganisms vs. Commercially less interesting microorganisms
14 Chlamydia trachomatis HIV HBV HCV HPV (CMV, EBV)
15 Roche Abbott Digene (Qiagen) Bayer Organon Teknika/bioMerieux Gen-Probe Becton-Dickinson PCR LCR, PCR Hybrid Capture b-dna, TMA NASBA TMA SDA
16 Cobas Ampliprep/TaqMan system (Roche)
17 Molecular diagnostic systems fully automated sample-to-result fashion - multiple tests performed concordantly - sample number flexibility - STAT test prioritization - random access
18 Panther System (Hologic-Gen-Probe)
19 Cobas 6800/8800 (Roche)
20 Molecular methods Commercially interesting microorganisms vs. Commercially less interesting microorganisms
21
22 automated isolation of DNA or RNA + real-time PCR
23 automated isolation of DNA or RNA + real-time PCR
24
25
26 automated isolation of DNA or RNA + real-time PCR
27 Real-time PCR PCR instrumentation and chemistry which allow the simultaneous amplification and quantification of specific nucleic acid sequences a combination of rapid thermal cycling and cycle-by-cycle basis detection of the reaction kinetics
28 Integrated systems automated isolation of DNA or RNA + real-time PCR
29
30 BD MAX System (Becton Dickinson) Jaguar system (HandyLab)
31 GeneXpert (Cepheid) single-use disposable cartridges
32 3M Integrated Cycler (Focus)
33 FilmArray (Idaho Technology; BioFire Diagnostics; BioMerieux)
34 FDA approved: October 12, 2015
35
36 Evaluating Multiplex Syndromic Panels? Improved Test Performance Improved Patient Care Improved Clinical and Cost Outcomes
37 Clin Infect Dis 2016;62:817-23
38 FDA approved: October 12, 2015
39 J Clin Microbiol 2016;54:785-7
40
41 - specificity 1544/1556 = 99.2 % - 12 positives = 5 true positives and 7 false positives
42 standardisation automation miniaturisation
43 Lab-on-a-Chip microfluidic device that has closed channels, wells, pumps, virtual or micromechanical valves and other structures in which the sample is manipulated chemical reactions at a scale that is 100 to 10,000-fold smaller than traditional assays
44
45 Pal R, Yang M, Lin R, et al. An integrated microfluidic device for influenza and other genetic analyses. Lab Chip 2005; 5:
46
47 deep sequencing next generation sequencing metagenomics microbiome
48 J Clin Microbiol 2016; 54:
49 J Clin Microbiol 2016; 54:
50
51 mbio 2016;7:3 - whole-genome sequencing of 308 invasive S. aureus isolates corresponding to a pan- European population snapshot - identification of high-risk clones on the basis of population level properties such as clonal relatedness, abundance, and spatial structuring and by inferring virulence and resistance properties on the basis of gene content - in silico predictions of antibiotic resistance profiles at least as reliable as phenotypic testing
52 J Clin Microbiol 2015;53: rapid identification of the bacterial species and simultaneous determination of their antibiotic susceptibility profiles initial short cultivation step in the absence and presence of different antibiotics combined with sensitive species-specific padlock probe detection of the bacterial target DNA to allow a determination of growth (i.e. resistance) and no growth (i.e. susceptibility) a proof-of-concept study: - urinary tract infections - antibiotic susceptibility profiles of E. coli for ciprofloxacin and trimethoprim - 100% accuracy in 3.5 h
53 . Diagnostic molecular microbiology: first and next 25 years Mario Poljak Institute of Microbiology and Immunology Faculty of Medicine, University of Ljubljana, Slovenia
54 3R rule Rapid Relevant Right (in clinically relevant time frames) (clinically relevant) (specific and sensitive, analytical category) Right > Relevant > Rapid Relevant = Rapid > Right
55 faster cheaper 24/7
56 Two testing places evolving concept H H H H POC POC POC POC clin micro lab POC = point-of-care
57 POC = point-of-care N Engl J Med 2013;368:
58 World's smallest PCR-based molecular diagnostics platform? Liat - Roche Cube - Spartan Bioscience Omni Cepheid Alere i - Alere/Abbott FlashDirect - Thermal Gradient Palm - Mesa Biotech Palm PCR - Ahram Biosystems
59 cobas Liat strep A assay vs. S. pyogenes LightCycler PCR assay sensitivity = 100% specificity = 98.3 % positive predictive value = 97.7% negative predictive value = 100.0% J Clin Microbiol 2016;54:815
60 Where is my instrument???
61 An ipad-like, sample-to-answer prototype Abou Tayoun AN et al. Am J Clin Pathol 2014;141:17-24.
62 A smartphone dongle as point of care device Sci Trans Med 2015; 7: 273re1
63 Lab-on-a-USB key microfluidic devices integrated with USB key data storage devices a device could be attached to other computational devices such as a cell phone or laptop computer to control molecular assays being done on the microfluidic biochip analysis transmitted to central databases for shared use and metaprocessing
64 J Clin Virol 2015;69:16-21
65 No electricity??
66 Solar thermal PCR system Sci Rep 2014;4:4137.
67 PATH NINA heater low-cost, electricity-free heater using an exothermic reaction thermally coupled with a phase change material thermal standard deviation <0.5 C at operating temperature a cost of approximately 0.06 USD per test for heater reaction materials HIV LAMP amplicon detection via Milenia test strips PLoS One 2014;9:e
68 rapid (<30 min) and sensitive (<10 copies) visual detection of amplified products using ph-sensitive dyes with minimal buffering capacity achieved with loop-mediated isothermal amplification (LAMP) specificity sensitivity
69 J Virol Methods 2016;234:90-5 gold nanoparticles (AuNP) attached to a single-stranded DNA probe for HPV16 and HPV18. LAMP incubation time of 20 min and a temperature of 65 C detection of the LAMP product by AuNP color change after LAMP amplification its products were hybridized with the AuNP probe for 5 min and then detected by the addition of magnesium salt
70 No electricity?? No instrument???
71 Ustar Biotechnologies (Hangzhou, China) Cross Priming Amplification technology developed by Qimin You, while conducting research in Canada & US - instrument free specimen processing - isothermal nucleic acid amplification - visual read-out detection and easy data interpretation - cross contamination prevention - glassified reagents for ambient temperature transport and storage
72 Non-microorganism detection based molecular diagnostic approach? (i)
73 direct detection of the presence of microorganism(s) in clinical specimens determination of gene expression patterns in patient s blood mononuclear cells specific for particular microorganism(s)
74 Sci Transl Med 2013;5:203ra126 Sci Transl Med 2016;8:322ra11 J Infect Dis 2015;212: adults vs. 41 healthy volunteers sensitivity 89% specificity 94% overall accuracy 87% - 238/273 concordant with clinical adjudication 118 patients sensitivity 95% specificity 92%
75 Transcriptional profile discrimination between bacterial and viral lower respiratory tract infection (LRTI) Suarez et al., J Infect Dis 2015;212:
76 culture-confirmed tuberculosis vs. culture-negative tuberculosis, diseases other than tuberculosis, latent tuberculosis 51-transcript signature identified that distinguishing tuberculosis from other diseases in the South African and Malawian children a risk score based on the signature for tuberculosis and for diseases other than tuberculosis showed a sensitivity of 82.9% (68.6 to 94.3) and a specificity of 83.6% (74.6 to 92.7) for the diagnosis of culture-confirmed tuberculosis the sensitivity of the Xpert MTB/RIF assay for molecular detection of M. tuberculosis DNA in cases of culture-confirmed tuberculosis was 54.3% (37.1 to 68.6), specificity 100% RNA expression signatures provided data that helped distinguish tuberculosis from other diseases in African children with and those without HIV infection
77 - prospective cohort study - Healthy South African adolescents; years; infected with M. tuberculosis for 2 years - a prospective signature of risk derived from whole blood RNA sequencing data by comparing participants who developed active tuberculosis disease (progressors) with those who remained healthy (matched controls) - 46 progressors and 107 matched controls - 16 gene signature of risk identified Lancet 2016;387: the signature predicted tuberculosis progression with a sensitivity of 66.1% (95% CI ) and a specificity of 80.6% (95 CI ) in the 12 months preceding tuberculosis diagnosis
78 Non-microorganism detection based molecular diagnostic approach? (ii)
79 Categorising tumours by the genetic and epigenetic changes in their cells, rather than by anatomy and histology
80 mbio 2014; 5:e
81 J Virol 2014; 88: modulating the host response is a promising approach to treating influenza host transcriptomic profiling used to computationally predict drugs that reverse the host response to H7N9 infection six FDA-approved drugs identified that could potentially be repurposed to treat H7N9 and other pathogenic influenza viruses
82 Molecular real-time in vivo tests?
83 rapid detection and localization of bacterial infections in living animals Nat Med 2014;20:301-6 molecular imaging approach for the specific, noninvasive detection of S. aureus based on the activity of the S. aureus secreted nuclease, micrococcal nuclease several short synthetic oligonucleotides, rendered resistant to mammalian nucleases by various chemical modifications and flanked with a fluorophore and quencher
84 Surprise with revolutionary non-molecular technology?
85 16S RNA sequencing for bacterial identification
86 intrinsic fluorescence spectroscopy of whole cells mbio 2013;4:e multistage algorithm correctly classified 99.6% of unknown samples to the Gram level, 99.3% to the family level, and 96.5% to the species level
87 Emerg Infect Dis 2015;21: second noninvasive diagnosis of Plasmodium falciparum infection without drawing blood or using any reagent
88 Clin Infect Dis 2014;59: thermal desorption-gas chromatography/mass spectrometry - prospectively collected breath samples - patients with proven or probable invasive aspergillosis vs. patients without aspergillosis detection of α-trans-bergamotene, β-trans-bergamotene, a β-vatirenene like sesquiterpene, or trans-geranylacetone identified patients with invasive aspergillosis with 94% sensitivity (95% CI, 81% 98%) and 93% specificity (95% CI, 79% 98%)
89 Relative abundance of Aspergillus terpene metabolites in the breath Clin Infect Dis 2014;59:
90 Journal of Clinical Microbiology 2012; 50:
91 Current tuberculosis diagnostics pipeline Pai M, Schito M. J Infect Dis 2015;211:S21-8.
92 Intelligent chips?
93 remote controller Ehrlich GD et al. Intelligent hip implants to battle biofilms. ASM News 2004; 70: remote controller
94 JAMA Published online June 23, 2016 glucose levels in sweat; sodium and chloride levels in sweat
95 Molecular methods - summary dramatically changed clinical microbiology have become more standardized, accurate, reliable, automated, rapid, costeffective, and their clinical value for the diagnosis and management of a several infectious diseases has been proven when applied wisely and selectively, molecular testing represents indispensable part of the routine laboratory practice of clinical microbiologist today future is bright with many promising technologies in pipeline
96 Supplementary slides
97 Molecular testing in clinical microbiology (i) Detection of microorganisms: - that grow slowly in culture (mycobacteria, chlamydia, Bordetella pertussis), - for which reliable cultivation methods are not widely available or not existing (Tropheryma whippelii, human papillomaviruses, novel parvoviruses and novel polyomaviruses), - for minimizing the spread of antimicrobial-resistant bacteria in health care institutions (methicillin resistant S. aureus), - when high possibility of false-negative culture result exists due to current antibiotic therapy (Neisseria meningitidis, Streptococcus pneumoniae, endocarditis), - when cultivation methods are too slow and insensitive for clinically relevant decisions and/or are not cost-effective (HSV encephalitis, enteroviral and parechoviral meningitis, CMV and EBV infection in immunocompromised individuals). - in archival clinical specimens (paraffin-embedded tissue, Pap smears, Giemsa-stained slides)
98 Molecular testing in clinical microbiology (ii) Diagnosis of selected viral infections: - in early phase of acute infection e.g. before seroconversion or in individuals with indeterminate results of confirmatory tests (HIV, HBV, HCV), - in infants born to infected mothers (HIV, HCV, CMV), - for screening of blood, organ and tissue donors in addition to conventional serological markers (HIV, HCV, HBV, West Nile virus), - for resolving diagnostic uncertainties following serological testing (HIV, HCV, HBV).
99 Molecular testing in clinical microbiology (iii) Molecular identification: - slow growing bacteria (mycobacteria) and fungi, - when common bacteria exhibits an unusual phenotypic pattern (optochin-resistant S. pneumoniae, Pseudomonas aeruginosa in cystic fibrosis patients), - when conventional phenotypic methods are not reliable (nonfermenting Gram negative rods), - simultaneous detection and identification of several microorganism in a single test (respiratory viruses, central nervous system infections, diarrheal diseases), - identification of pathogens for which non-molecular tests are not available (novel parvoviruses, novel polyomaviruses).
100 Molecular testing in clinical microbiology (iv) Molecular detection of antimicrobial resistance: - in bacteria with well defined genetic background of resistance (methicillin resistance in S. aureus, glycopeptide resistance in enterococci, rifampin resistance in M. tuberculosis) - in viruses where phenotypic susceptibility testing is too slow and/or too expensive (HIV, CMV) or not existing (HBV, HCV). Prognosis: - disease progression (HIV-1 viral load, HBV viral load, HPV partial genotyping), - progression to death (HIV-1 viral load), - for predicting risk and distinguishing active disease from asymptomatic infection in transplant recipients (CMV viral load, EBV viral load, BK polyomavirus viral load).
101 Molecular testing in clinical microbiology (v) Prediction and monitoring: - patient response to antiviral therapy (HIV viral load and drug resistance testing in HIV-infected individuals; viral genotype, viral load and IL-28 polymorphism in HCV-infected patients, HBV viral load in HBVinfected patients; drug resistance testing in CMV-infected transplant recipients), - determination of duration of antiviral therapy (viral genotype, viral load kinetics and IL-28 polymorphism in HCV-infected patients), - guiding clinicians in initiating (determination of HIV viral tropism) and changing antiviral therapy (HIV, HBV and CMV drug resistance testing), - deciding when to initiate preemptive therapy in transplant recipients (CMV viral load).
Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays
About the author Disclaimer EXECUTIVE SUMMARY Molecular diagnostic technologies Healthcare-associated infections Sexually transmitted HPVs HIV and hepatitis viruses Market outlook and forecasts Molecular
More informationTrends in molecular diagnostics
Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling
More informationChain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host
Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University
More informationCorporate Medical Policy
Corporate Medical Policy Identification of Microorganisms Using Nucleic Acid Probes File Name: Origination: Last CAP Review: Next CAP Review: Last Review: identification_of_microorganisms_using_nucleic_acid_probes
More informationMolecular Diagnostics at Point of Care It s The Future Already. Ack!
Molecular Diagnostics at Point of Care It s The Future Already. Ack! Sheldon Campbell M.D., Ph.D. Pathology and Laboratory Medicine, VA Connecticut Department of Laboratory Medicine, Yale School of Medicine
More informationDiagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)
Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves
More informationIP Lab Webinar 8/23/2012
2 What Infection Preventionists need to know about the Laboratory Anne Maher, MS, M(ASCP), CIC Richard VanEnk PhD, CIC 1 Objectives Describe what the laboratory can do for you; common laboratory tests
More informationTest Requested Specimen Ordering Recommendations
Microbiology Essentials Culture and Sensitivity (C&S) Urine C&S Catheter Surgical (excluding kidney aspirates) Voided Requisition requirements o Specific method of collection MUST be indicated o Indicate
More informationJefferies Healthcare Conference. John Bishop Chairman & CEO June 2, 2014
Jefferies Healthcare Conference John Bishop Chairman & CEO June 2, 2014 1 Cepheid Cepheid Worldwide Market Growth by Segment Overall IVD sales are projected to grow at a 5.9% CAGR through 2017. Molecular
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Issue date: 17 August 2016 Worcestershire Royal Hospital Contact: Peter Jackson Microbiology Laboratory Tel: +44 (0) 1905 760192 Ext 30659
More informationAMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS
AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS Take Control, Molecular Control. 02 04 05 06 06 07 08 08 AMPLIRUN TOTAL RESPIRATORY INFECTIONS TUBERCULOSIS INFECTIONS GASTROINTESTINAL
More informationNew Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention
New Generation of Nucleic Acid Testing Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention Percentage (%) Persons Living with Diagnosed or Undiagnosed HIV Infection
More informationMENU PRODUCT MOLECULAR. International Product Listing. Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs
International Product Listing MOLECULAR PRODUCT MENU Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs Products are not intended for donor screening. Simplexa Molecular Kits
More informationThe Application of molecular POCT for Influenza and Group A Strep Detection
The Application of molecular POCT for Influenza and Group A Strep Detection Gregory J. Berry, Ph.D., D(ABMM) Assistant Professor, Pathology and Laboratory Medicine Zucker School of Medicine at Hofstra/Northwell
More informationRetrospective and Prospective Verification of the Cepheid Xpert Flu Assay
JCM Accepts, published online ahead of print on 20 July 2011 J. Clin. Microbiol. doi:10.1128/jcm.01162-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationPCR Is Not Always the Answer
PCR Is Not Always the Answer Nicholas M. Moore, PhD(c), MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted
More informationMultiplexing; what is it good for? Dr. S.M. Jazayeri MD, PhD, Virologist. Tehran University of Medical Sciences
Multiplexing; what is it good for? Dr. S.M. Jazayeri MD, PhD, Virologist Tehran University of Medical Sciences In a clinical laboratory setting In a clinical laboratory setting 1.Speed is utmost In a clinical
More informationMolecular Diagnostics at Point of Care When will we get there; and where is there anyway?
Molecular Diagnostics at Point of Care When will we get there; and where is there anyway? Sheldon Campbell M.D., Ph.D. Pathology and Laboratory Medicine, VA Connecticut Department of Laboratory Medicine,
More informationPotential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.
In the name of God Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress
More informationCONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP
CONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP ERIN H. GRAF, PHD, D(ABMM) Director, Infectious Disease Diagnostics Laboratory Assistant Professor, Clinical Pathology and
More informationDiagnosis of infectious diseases and confirmation of diagnosis. Molecular epidemiology of emerging/re-emerging pathogens
LA PREPARAZIONE E LA RISPOSTA ALLE EMERGENZE INFETTIVE Padova, 20 settembre 2012 Laboratory advanced technologies in the support of Public Health interventions in infectious disease emergencies Prof. Giorgio
More informationS. Wesley Long, MD, PhD
Basic Molecular Microbiology: A Practical Case-Based Approach S. Wesley Long, MD, PhD Center for Molecular and Translational Human Infectious Diseases Research Houston Methodist Research Institute September
More informationCommercial Assays an Overview. Molecular Workshop
Commercial Assays an Overview Molecular Workshop Commercial Assays By Discipline Infectious Disease Blood borne viruses Respiratory Viruses and Bacteria Enteropathogens STD s bacteria, viruses and parasites,
More informationDiagnostics: Bench to Bedside Pathway
Diagnostics: Bench to Bedside Pathway Rosanna W Peeling Professor and Chair, Diagnostic Research Director, International Diagnostics Centre London School of Hygiene & Tropical Medicine www.idx-dx.org The
More informationPoint of Care (POC) diagnostics for microbial infections and POC susceptibility measurements: The need in Indian context. Dr.
Point of Care (POC) diagnostics for microbial infections and POC susceptibility measurements: The need in Indian context Dr. Ramesh Paranjape Definition of POC a medical test that is conducted at or near
More informationMolecular Diagnosis Future Directions
Molecular Diagnosis Future Directions Philip Cunningham NSW State Reference Laboratory for HIV/AIDS & Molecular Diagnostic Medicine Laboratory, SydPath St Vincent s Hospital Sydney Update on Molecular
More informationAdvances in Pathogen Detection and Diagnostic Tools for Infectious Diseases. Maria Rosario Z. Capeding, MD, FPPS, FPIDSP
Advances in Pathogen Detection and Diagnostic Tools for Infectious Diseases Maria Rosario Z. Capeding, MD, FPPS, FPIDSP The Future of Microbiology The Future (can machine replace human being?) Why do we
More informationPATHOGEN DETECTION WITH THE FILMARRAY
PATHOGEN DETECTION WITH THE FILMARRAY The System Sample-to-Answer in an Hour Single sample Multiple samples The FilmArray integrates sample preparation, amplification, detection, and analysis all into
More informationMicrobiology EQA Product Portfolio
Labquality EQAS Microbiology EQA Product Portfolio Clinically relevant external quality assessment program for microbiology Bacterial serology Bacteriology Mycology Parasitology Preanalytics Virology Labquality
More informationPoint of Care Tests for respiratory viruses: impact on clinical outcomes of patients
Point of Care Tests for respiratory viruses: impact on clinical outcomes of patients Dr Sacha Stelzer-Braid Postdoctoral Scientist Virology Research Laboratory (VRL), UNSW and POWH @DrSachaSB Outline 1.
More informationKhalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia
1 Regional Lab, Makkah. Saudi Arabia stract: Clinical specificity and genotype/subtype detection of viruses using the Cobas TaqScreen MPX system V 2.0, which is a nucleic acid test (NAT) that uses multiples
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationWHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx
WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere q HIV-1/2 Detect WHO reference number: PQDx 0226-032-00 Alere q HIV-1/2 Detect with product codes 270110050, 270110010 and 270300001,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Absidia infections, 324 AccuProbe, for nontuberculous mycobacteria, 282 Achromobacter infections, in cystic fibrosis, 207 208 Acid-fast
More informationpoint-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital
point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital laboratory performed by a health care professional or non-medical
More informationHuman Papillomaviruses: Biology and Laboratory Testing
For our patients and our population Human Papillomaviruses: Biology and Laboratory Testing Geoffrey Higgins Microbiology and Infectious Diseases For our patients and our population HPV Associated Cancers
More informationAbout HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at
Cervical Cancer & HPV What is HPV Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. About HPV Theree are more than 100 types of HPV, of which at least 13 are cancer-causing
More informationClinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis
Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Amit S. Chitnis, MD, MPH; Pennan M. Barry, MD, MPH; Jennifer M. Flood, MD, MPH. California Tuberculosis Controllers
More informationTB Laboratory for Nurses
TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety
More informationNon-competitive Internal Control Concept for PCR-based Qualitative Assays
Christian O. Simon Roche Molecular Diagnostics Rotkreuz, CH Non-competitive Internal Control Concept for PCR-based Qualitative Assays 23 rd SoGAT Meeting, 16 th 17 th April, 2012, Vilnius, Lithuania Design
More informationPAMET Continuing Education 2016
PAMET Continuing Education 2016 Agent of gastroenteritis Medium/method] used for routine screening/detection in stool samples Salmonella, Shigella, MacConkey, Hektoen, Bismuth sulfite,etc. Plesiomonas
More informationPractical Aspects of Standardisation for a Global Controls Manufacturer
Practical Aspects of Standardisation for a Global Controls Manufacturer MRSA SoGAT Clinical Diagnostic Meeting NIBSC, UK June 25, 2008 Frank Opdam PhD, AcroMetrix Standardisation A fundamental goal of
More informationHBV PUBLIC HEALTH IMPLICATIONS
جزايری دکتر سيد محمد آزمايشگاه ھپاتيت B -دانشکده بھداشت ويروس شناسی- گروه دانشگاه علوم پزشکی تھران کنگره ارتقا کيفيت- ١٣٩٢ HBV PUBLIC HEALTH IMPLICATIONS 2 billion people have been infected by HBV worldwide.
More informationRespiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract
Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory
More informationTypes of infections & Mode of transmission of diseases
Types of infections & Mode of transmission of diseases Badil dass Karachi King s College of Nursing Types of Infection Community acquired infection: Patient may acquire infection before admission to the
More informationTable of Contents (continued)
Emerging Molecular and Immunohematology Blood Typing, Grouping And Infectious Disease NAT Screening Assays And Companies Developing New Technologies and Products Table of Contents 1. Blood Typing and Grouping
More informationONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing
SUMMARY OF ANTIMICROBIAL ACTIVITY ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing Description One Step is an effective economical 4 ounce per gallon disinfectant, specifically
More informationof clinical laboratory diagnosis in Extra-pulmonary Tuberculosis
New approaches and the importance of clinical laboratory diagnosis in Extra-pulmonary Tuberculosis Bahrmand.AR, Hadizadeh Tasbiti.AR, Saifi.M, Yari.SH, Karimi.A, Fateh.A, Tuberculosis Dept. Pasteur Institute
More informationCOMMUNICABLE DISEASE REPORT
June 2011 Department of Health and Community Services Government of Newfoundland and Labrador COMMUNICABLE DISEASE REPORT Reporting Sexually Transmitted and Bloodborne Infections All laboratory-confirmed
More informationSample Selection, Collection, Transport: Issues & Challenges
Sample Selection, Collection, Transport: Issues & Challenges Jim Dunn, PhD, D(ABMM) Director, Medical Microbiology and Virology Texas Children s Hospital LEARNING OBJECTIVES 1. Identify factors to consider
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of Accreditation 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK National Infection Service, Public Health England Colindale 61 Colindale Avenue London NW9 5EQ Contact: Dr Sanjiv
More informationAmerican Association for Clinical Chemistry Emerging Clinical & Laboratory Diagnostics: The Portable Lab April 24-25, 2014
Barry Lutz University of Washington Department of Bioengineering Key collaborators: Paul Yager, UW BioE Elain Fu, Oregon State University American Association for Clinical Chemistry Emerging Clinical &
More informationHIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)
HIV Update in Laboratory Testing Patricia Slev, PhD, D(ABCC) Objectives Explain the advances in HIV diagnostics, including fourth generation Ag/Ab combination HIV screening assays Describe the new CDC
More informationAntimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association
Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationPCR Is Not Always the Answer
PCR Is Not Always the Answer Nicholas M. Moore, PhD, MS, MLS(ASCP) CM Assistant Director, Division of Clinical Microbiology Assistant Professor Rush University Medical Center Disclosures Contracted research:
More informationXpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it
Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it Angela Starks, PhD Chief, Laboratory Branch Division of TB Elimination Matt Bankowski, PhD, MS, D(ABMM), HCLD/CC(ABB)
More informationNorgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product# 33840 Product Insert Intended
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Royal Liverpool & Broadgreen University Hospitals NHS Trust Department of Virology Liverpool Clinical Laboratories Royal Liverpool and Broadgreen
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Department of Microbiology Princess Alexandra Hospital Hamstel Road Harlow CM20 1QX Contact: D Orriss Tel: +44 01279 827138 E-Mail: Debbie.Orriss@pah.nhs.uk
More informationFifteen years of molecular EQA: progress and challenges
Fifteen years of molecular EQA: progress and challenges Anton M van Loon 1, Stuart West 2 and Paul Wallace 2 1 Department of Virology, UMC Utrecht, The Netherlands 2 QCMD, Glasgow, Scotland Key Issues
More informationNucleic Acid Amplification Testing for the Diagnosis of TB
Roche Nucleic Acid Amplification Testing for the Diagnosis of TB David Warshauer, PhD Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene 19 th /20 th Century Traditional Algorithm
More informationالحترمونا من خري الدعاء
الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or
More informationAppropriate utilization of the microbiology laboratory. 11 April 2013
Appropriate utilization of the microbiology laboratory 11 April 2013 Lecture Plan Revision of infectious disease Triad of infectious disease Interaction between host and infectious agent Pathogenesis Phases
More informationMicrofluidic chip-based diagnostics of cervical cancer
Microfluidic chip-based diagnostics of cervical cancer Liv Furuberg Chief Scientist, SINTEF Michal Mielnik, Ib-Rune Johansen, Anja Gulliksen, Lars Solli, Tobias Baier, Thomas Hansen-Hagge, Rainer Gransee,
More informationRobert G. Gish MD UC San Diego
Robert G. Gish MD UC San Diego The Pipeline of HIV-Related Point-Of- Care Tests is Growing Viral detection Examples: 2012 2013 2014 2015 2016 2017 CD4 test Examples: 2009 2010 2011 2012 2013 0 2014 Evidence
More informationQUALITY CONTROL for MOLECULAR DIAGNOSTICS Quality issues highlighted through international external quality assessment
QUALITY CONTROL for MOLECULAR DIAGNOSTICS Quality issues highlighted through international external quality assessment William G MacKay PhD Neutral Office Coordinator QCMD The Altum Building, Todd Campus
More information3base The Science Behind EasyScreen Molecular Diagnostic Assays. Nucleic Acid Conversion Technology
3base The Science Behind EasyScreen Molecular Diagnostic Assays Nucleic Acid Conversion Technology 1 Topics 3base Technology Overview Technical Advantages of 3base Validation of 3base Specificity Validation
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More informationNew CT/GC Tests. CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009
CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009 Richard Steece, Ph.D., D(ABMM) DrRSteece@aol.com New CT/GC Tests New Nucleic Acid Amplification Tests (NAATs) for
More informationFILMARRAY: CAN IT MAKE A DIFFERENCE FOR CSF TESTING L O U I S E O S U L L I V A N, M M U H O S U L L I V A N M A T E R. I E
FILMARRAY: CAN IT MAKE A DIFFERENCE FOR CSF TESTING L O U I S E O S U L L I V A N, M M U H O S U L L I V A N L @ M A T E R. I E Level 4 teaching hospital based in Dublin s north inner city Over 600 in-patient
More informationFresh Citrus Disinfectant Cleaner
SUMMARY OF ANTIMICROBIAL ACTIVITY Fresh Citrus Disinfectant Cleaner Description Fresh Citrus Disinfectant Cleaner is an effective economical 4 ounce per gallon disinfectant, specifically designed for hospitals,
More informationInfectious Disease Diagnostics
Infectious Disease Diagnostics Tackling Infectious Diseases Uppsala Health Summit - October10 th, 2017 Stephan Jäger, Roche Diagnostics GmbH When to tackle infectious diseases Prevention & action contribution
More informationMultiplex Syndromic Testing s Effect on Public Health Molecular Testing & Emerging Technology WCLN Workshop April 28, 2016
Multiplex Syndromic Testing s Effect on Public Health Molecular Testing & Emerging Technology- 2016 WCLN Workshop April 28, 2016 Objectives Learn what current multi-target testing activities are ongoing
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationThe Role of POCT in Management of Infectious Disease in the Critical Care Setting
The Role of POCT in Management of Infectious Disease in the Critical Care Setting Nathan A Ledeboer Associate Professor of Pathology Medical College of Wisconsin Medical Director, Microbiology and Molecular
More informationR&D AND INNOVATION. Francesco Colotta Senior Corporate VP and Chief Medical Officer
R&D AND INNOVATION Francesco Colotta Senior Corporate VP and Chief Medical Officer IN VITRO DIAGNOSTICS: BASICS DETECTION IN BIOLOGICAL FLUIDS... E.G. BLOOD, URINE, CSF, IN VITRO DIAGNOSTICS...OF A MOLECULE......
More informationLearning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016
New HIV Testing Algorithm from CDC ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Learning Objectives Following attendance and review of material provided, attendees will be able to: 1. Describe the new
More informationTranspla. antation. Associate Professor of Medical Virology Virology Research Center Shahid Beheshti University of Medical Sciences
Viral Mo olecular Diagno osis in Transpla antation Seyed Alireza Nadji, Ph.D. Associate Professor of Medical Virology Virology Research Center Shahid Beheshti University of Medical Sciences Which techniques
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationAnti-Infective Clinical Trials
Anti-Infective Clinical Trials The extensive clinical training and experience of our infectious disease staff places us in a unique position to fully appreciate the requirements of our clients conducting
More informationSimultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR (1167)
From the Japanese Association of Medical Sciences The Japanese Association for Infectious Diseases Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR
More informationM. Khanna and S. Visuri
The ProPneumo1 Assay: Detection of Chlamydophila pneumoniae, Mycoplasma pneumoniae, and an Internal Control Using Multiplex PCR on Multiple Real Time PCR Systems S. Dollhopf,, W. Majewski,, P. Douglass,
More informationProfessor Jonathan Ross
SECOND JOINT CONFERENCE OF BHIVA AND BASHH 2010 Professor Jonathan Ross Whittall Street Clinic, Birmingham COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Professor Ross has received
More informationLack of Significant Co-Activation of BKV and CMV in Renal Transplant Patients: An Institutional Experience
Volume 1, Issue 1, pp: 1-6 Research Article Introduction Open Access Lack of Significant Co-Activation of BKV and CMV in Renal Transplant Patients: An Institutional Experience Minh-Thu Nguyen, BS 1, Phylicia
More informationPotential Reimbursement CPT Codes
BioFire FilmArray Blood Culture Identification (BCID) Panel Medicare All targets (n) 87150 n x * *BioFire BCID Panel is comprised of 27 total targets. The number of targets allowed for reimbursement may
More informationNon-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique
More informationQUANTITATIVE HIV RNA (VIRAL LOAD)
CLINICAL GUIDELINES For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS QUANTITATIVE HIV RNA (VIRAL LOAD) Policy Number: PDS - 008 Effective Date: October
More informationNew diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018
New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with
More informationFor purification of viral DNA and RNA from a wide range of sample materials
QIAamp virus kits For purification of viral DNA and RNA from a wide range of sample materials Automatable on QIAGEN s proven QIAamp Kits set the standard for purification of viral DNA and RNA. QIAamp virus
More informationClinical Microbiology CLS 2019 Clinical Microbiology Laboratory Scheme Application Form
Laboratory Scheme Application Form complete all sections below and return to LGC Standards Proficiency Testing by email, fax or post. Returning customer Lab ID: Purchase order no.: (compulsory) Round Despatch
More informationGLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES PHM005C January 2013 Peggy Lehr Project Analyst ISBN: 0-89336-646-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationDonor Screening in The Region. Vincini GA NRL, Melbourne, Australia
Donor Screening in The Region Vincini GA NRL, Melbourne, Australia NRL Established in 1985 Not-for-profit organisation that exists to support laboratories that perform testing for the diagnosis and management
More informationChapter 19: The Genetics of Viruses and Bacteria
Chapter 19: The Genetics of Viruses and Bacteria What is Microbiology? Microbiology is the science that studies microorganisms = living things that are too small to be seen with the naked eye Microorganisms
More informationUPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH. Dr Arlo Upton Clinical Microbiologist Labtests Auckland
UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH Dr Arlo Upton Clinical Microbiologist Labtests Auckland Talk outline Chlamydia trachomatis NAAT What does a positive test mean Interpreting low level positives
More informationPoint of care testing for respiratory viruses
Point of care testing for respiratory viruses Jen Kok Medical Virologist Centre for Infectious Diseases and Microbiology Laboratory Services Pathology West ICPMR Westmead Hospital jen.kok@health.nsw.gov.au
More informationAll living creatures share two basic purposes 1. survival 2. reproduction
Infectious Diseases All living creatures share two basic purposes 1. survival 2. reproduction *Organisms must take nutrients essential for growth and proliferation from the environment. *In many conditions
More informationINFINITI FLU A-sH1N1 Assay Directional Package Insert (DPI)
INFINITI FLU A-sH1N1 Assay Directional Package Insert (DPI) For In Vitro Diagnostic Use FOR EXPORT ONLY Manufactured by AutoGenomics, Inc., 2980 Scott Street, Vista, CA USA 92081 Authorized EU Agent: BÜHLMANN
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory
More informationThe clearest path to the most meaningful results. The cobas HPV Test delivers clinical value with workflow efficiencies every step of the way
The clearest path to the most meaningful results The cobas HPV Test delivers clinical value with workflow efficiencies every step of the way The cobas HPV Test KNOW THE RISK Help guide clinical decision
More information